Background：Type I protein arginine N-methyltransferases （PRMTs）, such as PRMT3, catalyze the formation of asymmetric N（G）,N（G）-dimethylarginine （ADMA） residues in proteins （Tang et al., 1998 [PubMed 9642256]）.
仕様
Synonyms：2010005E20Rik,2410018A17Rik,AL033309,ANM3,Heterogeneous nuclear ribonucleoprotein methyltransferase 1-like 3,Heterogeneous nuclear ribonucleoprotein methyltransferase like 3,Heterogeneous nuclear ribonucleoprotein methyltransferase like protein 3,Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 3,HMT1 hnRNP methyltransferase like 3,HMT1 hnRNP methyltransferase like 3 S. cerevisiae,HMT1-like 3,hnRNP methyltransferase like 3,HRMT1L3,PRMT 3,PRMT3,Protein arginine methyltransferase 3,Protein arginine N methyltransferase 3,Protein arginine N-methyltransferase 3
Host：Rabbit
Reactivity：Human
Applications：IHC,ELISA
Concentration：0.3mg/mL
Immunogen：Synthetic peptide of human PRMT3
Purification Method：Affinity purification
Clonality：Polyclonal
Conjugation：Unconjugated
Buffer：PBS with 0.05％ sodium azide, 50％ glycerol, PH7.3
Dilution：IHC 1：50-1：200
Swissprot：O60678
Isotype：IgG
Research Areas：Cancer, Epigenetics and Nuclear Signaling
